using mrd negativity to measure depth of response & to discontinue treatment in multiple myeloma
Published 1 year ago • 206 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
3:16
developing patient-specific mrd markers for predicting and preventing mds relapse post-sct
-
1:05
the importance of using mrd to guide treatment decisions in all
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
1:44
how mrd assessment can inform treatment decisions in aml
-
0:51
machine learning-based sequential analysis to assist selection between vmp & rd for ndmm
-
2:21
evaluation of a novel blood pressure scoring method
-
8:15
progression free survival and overall survival in nadim ii study — dr. mariano provencio
-
14:37
progress report v - ruben borbély
-
7:58
asco coverage: dr. agarwal discusses dna damage repair mutations in prostate cancer
-
3:18
midiagnostics' complete blood count (cbc) - blood analysis for diagnosis and monitoring
-
0:57
evaluating ways of measuring mrd in hematologic malignancies
-
1:56
medical report analyzer
-
57:19
hematuria: evaluation with dr. stephen lieberman - december 13, 2023
-
2:21
final analysis from the randomized phase 3 innovatetm study
-
1:27
how to request an update to your study record at the isrctn registry
-
11:14
progress report i - péter márton
-
11:05
progress report iii - péter márton
-
15:22
progress report v - márk hernádfői
-
13:41
progress report iii - dániel horváth
-
15:15
progress report ii - lőrinc andrás ulmann